Foresight Diagnostics Patent Issued for Minimal Residual Disease Detection Technology
The USPTO granted Foresight Diagnostics a patent for the detection of MRD using its personalized phased variant detection platform.
Read More
Search Results for: lung cancer
FDA Approves Thermo Fisher’s NGS-based CDx Test for RET-Positive Thyroid Cancer
The Oncomine Dx Target test was approved as a CDx for a therapy targeting RET-positive thyroid cancer and RET-positive NSCLC.
Read More
Biosensor Detects Brain Tumors with Less Than a Drop of Blood
Researchers have developed a biosensor that could help physicians precisely diagnose brain cancer from a minute blood sample.
Read More
Cost-Effective Approach to Early Detection of Cancer Tested
UCLA researchers have found a cost-effective way for early detection of cancer using cell-free DNA in blood samples.
Read More
Cancer-Detecting Blood Test Offered
Patients at St. Elizabeth Healthcare can be screened for 50 different types of cancer, thanks to a new cancer-detecting blood test.
Read More